• Shenqi Fuzheng, SRC/PI3K/AKT, and Glioma

  2026-10-01

  The 2024 Journal of Ethnopharmacology study combined network pharmacology with cellular and mouse experiments to investigate how Shenqi Fuzheng injection affects glioma proliferation and migration. Its main contribution is the identification and experimental support of SRC/PI3K/AKT signaling as a candidate mechanism, while its design also clarifies which findings remain hypothesis-generating for angiogenesis-focused research.

• Tacrine hydrochloride hydrate Research Workflows

  2026-10-01

  Build reproducible cholinesterase, neuroprotection, and toxicity workflows around Tacrine hydrochloride hydrate, from concentration selection to orthogonal validation. The guide distinguishes benchmark enzyme inhibition from broader Alzheimer’s disease research applications and provides practical troubleshooting for variable potency, precipitation, and cell stress.

• Cy5 TSA Fluorescence System Kit for Spatial Imaging

  2026-09-30

  The Cy5 TSA Fluorescence System Kit strengthens IHC, ICC, and FISH workflows when conventional fluorescence cannot resolve scarce targets. Its localized HRP-driven deposition supports far-red imaging, lower antibody or probe consumption, and practical validation of metastasis-associated markers.

• Amiloride (MK-870) Workflow Guide

  2026-09-30

  Build cleaner ion-transport and receptor-trafficking experiments with Amiloride (MK-870), using reversible pharmacology, matched controls, and time-resolved readouts. The guide translates ENaC, PC2, and uPAR-focused applications into practical workflows for sodium channel research, cystic fibrosis models, hypertension research, and cellular endocytosis modulation.

• NET-DNA, CCDC25, and ILC3 Repair

  2026-09-29

  A 2026 FASEB Journal study identifies NET-derived DNA as an inhibitor of ILC3-mediated intestinal repair in ulcerative colitis models. Its data connect NET-DNA sensing through CCDC25 with reduced IL-22 production, impaired epithelial barrier restoration, and a potential mechanism linking neutrophil activity to delayed mucosal healing.

• Protein Corona Effects on Nanoparticle Function

  2026-09-29

  Elizabeth Voke’s UC Berkeley dissertation develops a label-free, quantitative proteomics workflow for characterizing protein coronas on lipid nanoparticles in human plasma. Its central functional finding is that greater cellular uptake does not necessarily produce greater mRNA expression, highlighting lysosomal trafficking as an important variable in nanoparticle delivery studies.

• Dual-Action Inhibitors and p38α Dephosphorylation

  2026-09-28

  A 2024 bioRxiv preprint shows that some kinase inhibitors can both block p38α catalytic activity and accelerate removal of its activation-loop phosphate by the WIP1 phosphatase. Structural and biochemical evidence links this effect to an inhibitor-stabilized activation-loop conformation that exposes the phosphothreonine, suggesting a route to more durable and mechanistically specific kinase inhibition.

• Cy5 TSA for Spatial Mapping of HCC Lipid Biology

  2026-09-28

  See how the Cy5 TSA Fluorescence System Kit can support spatial investigation of lipid-metabolism markers in hepatocellular carcinoma. This article connects the miR-3180–SCD1–CD36 findings to practical assay design while explaining where signal amplification helps—and where it cannot replace biological controls.

• PF-562271 HCl for FAK/Pyk2 Cancer Research

  2026-09-27

  Use PF-562271 HCl to test how FAK/Pyk2 signaling contributes to adhesion, migration, and tumor-cell behavior—not as a stand-in for clinical CAML testing. This guide pairs a practical inhibitor workflow with the emerging evidence on circulating polyploid giant cancer macrophages, while clearly separating established findings from testable hypotheses.

• From Secretion Phenotypes to Testable Cell-State Biology

  2026-09-26

  Single-cell secretion profiling reveals why transcript levels alone can miss functional differences between cells. This article translates SEC-seq findings into a careful screening strategy for researchers evaluating 4-Methoxychalcone-1 without presuming an unverified mechanism or effect.

• PAD4-IN-2 TFA: Workflows for Tumor NET Research

  2026-09-25

  Use PAD4-IN-2 TFA to examine tumor-targeted PAD4 inhibition, histone H3 citrullination, and NET-linked metastasis without assuming direct tumor-cell killing. This guide translates preclinical findings into practical assay choices, controls, and troubleshooting steps for 4T1 and neutrophil-focused studies.

• Radiation Alters Neuronal Differentiation via PI3K–STAT3

  2026-09-25

  Eom and colleagues found that ionizing radiation promotes neurite outgrowth and neuronal marker expression in C17.2 mouse neural stem-like cells, while changing the expression pattern of genes linked to neuronal function. Inhibitor experiments implicated PI3K-dependent p53 and STAT3–mGluR1 signaling, and experiments with primary neural stem cells provided ex vivo support for the findings.

• Hypoxia and Immunometabolism in Tumors

  2026-09-24

  This 2025 review explains how hypoxia reshapes tumor and immune-cell metabolism, helping establish an immunosuppressive tumor microenvironment. Its central contribution is a connected framework for interpreting oxygen limitation, metabolic adaptation, and immune dysfunction, while highlighting why therapeutic strategies must account for interactions among tumor cells and their surroundings.

• Cy5 TSA Fluorescence System Kit for HCC Imaging

  2026-09-24

  Map low-abundance protein or nucleic-acid signals in tissue with localized Cy5 amplification, while using less primary antibody or probe than a conventional fluorescence workflow may require. This practical guide connects the Cy5 TSA Fluorescence System Kit to hepatocellular carcinoma research on miR-3180, SCD1, and CD36—with clear controls and optimization advice.

• HyperScribe™ Poly (A) Tailing Kit for mRNA Workflows

  2026-09-23

  Learn how to use enzymatic polyadenylation to prepare T7-generated RNA for translation-sensitive assays, with controls that separate RNA quality from biological effects. The workflow connects the HyperScribe™ Poly (A) Tailing Kit to HFM1 rescue research while making clear what a poly(A) tail can—and cannot—establish.

8098 records 1/540 page Next 12345 下5页 Last page